Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

Published:2023-12-19 Issue: Volume: Page:1-15
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Paredes-Ruiz Diana¹^ORCID,Martin-Iglesias Daniel¹^ORCID,Ruiz-Irastorza Guillermo¹²^ORCID

Affiliation:

1. Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, The Basque Country, Spain

2. Department of Medicine, University of the Basque Country, The Basque Country, Spain

Funder

Department of Education of the Basque Government

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2023.2294938

Reference118 articles.

1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update;Fanouriakis A;Ann Rheum Dis,2023

2. Combined mepacrine–hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity

3. A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus

4. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

5. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP